PDGFRβ signalling enhances tumor cell survival and promotes a more aggressive phenotype, which can contribute to the failure of chemotherapy [20], through mechanisms that involve PPAR-γ, a nuclear receptor that regulates genes involved in cell differentiation, lipid metabolism, and inflammation [21]. The gene discussed is PDGFRB; the disease is neoplasm.